Captiva Spine received a Notice of Allowance by the United States Patent and Trademark Office for their patent on the TransFasten® posterior sacroiliac (SI) joint fusion system. The patent addresses Quadracentric™ carpentry, which prepares the SI joint prior to surgery.
TransFasten is a precision-machined allograft with a large graft window that fits within the large cross-joint decortication to create biologic fusion.
Quadracentric site preparation is a form of mortise and tenon carpentry and requires just one implant, unlike other systems that require multiple implants or large screws.
“Recognizing the growing adoption of SI fusion procedures, we are committed to the continued development of differentiated and proprietary devices that clearly provide incremental improvement. This patent marks another milestone for Captiva Spine’s growing patent portfolio,” said Dale Mitchell, President of Captiva Spine. “TransFasten’s form of carpentry is truly aligned with key principles of achieving ease of use, stabilization, and fusion while utilizing a safe posterior approach.”